Literature DB >> 3132795

Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly.

A E Smals1, G F Pieters, A G Smals, P W Kloppenborg.   

Abstract

Sellar volume and both basal (r = +0.54, P less than 0.02) and GHRH-stimulated (r = +0.41, P less than 0.05) GH levels were directly correlated in a group of 28 patients with acromegaly as were the latter indices (r = +0.82, P less than 0.001). By subdividing the patients according to sex, a close relation between sellar size and both basal (r = +0.77, P less than 0.02) and stimulated GH (r = +0.71, P less than 0.02) was found only in the men, not in the women (r = +0.12 and r = +0.02, respectively, P greater than 0.10). The presence of a tight relation between sellar volume and basal and GHRH stimulated GH levels in male patients with acromegaly and its complete absence in women are equally intriguing and await further elucidation. A modulating role of gonadal steroids in the genesis of this sex differences remain to be assessed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132795     DOI: 10.1530/acta.0.1170387

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  5 in total

Review 1.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Gender- and age-related differences in the endocrine parameters of acromegaly.

Authors:  A Colao; G Amato; A M Pedroncelli; R Baldelli; S Grottoli; V Gasco; M Petretta; C Carella; G Pagani; G Tambura; G Lombardi
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

3.  Gender and age in the biochemical assessment of cure of acromegaly.

Authors:  P U Freda; R E Landman; R E Sundeen; K D Post
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

4.  Acromegaly: an epidemiological study.

Authors:  J Etxabe; S Gaztambide; P Latorre; J A Vazquez
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

5.  Medical therapy of acromegaly.

Authors:  U Plöckinger
Journal:  Int J Endocrinol       Date:  2012-04-10       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.